Report Summary
Eternity Insights has published a new study on Global Angiotensin II Receptor Market focusing on key segments as by Type (C-21, EMA-401, KDT-501, MOR-107, Others), by Application (Immunology, Respiratory, Women's Health, Acute Ischemic Stroke, Others), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Angiotensin II Receptor Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Angiotensin II Receptor Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Angiotensin II Receptor Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Angiotensin II Receptor Market Segmentation:
Angiotensin II Receptor Market, By Type
- C-21
- EMA-401
- KDT-501
- MOR-107
- Others
Angiotensin II Receptor Market, By Application
- Immunology
- Respiratory
- Women's Health
- Acute Ischemic Stroke
- Others
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Angiotensin II Receptor market in terms of demand generation. The Angiotensin II Receptor market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Angiotensin II Receptor market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Angiotensin II Receptor Market Taxonomy:
To learn more about this report
Global Angiotensin II Receptor Market Competitive Landscape
The global Angiotensin II Receptor market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- CJ HealthCare Corp
- MorphoSys AG
- Novartis AG
- Vicore Pharma AB
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
C-21, EMA-401, KDT-501, MOR-107, Others |
| By Application Outlook |
Immunology, Respiratory, Women's Health, Acute Ischemic Stroke, Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
CJ HealthCare Corp, MorphoSys AG, Novartis AG, Vicore Pharma AB |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Angiotensin II Receptor Market Overview
1.1 Angiotensin II Receptor Product Overview
1.2 Angiotensin II Receptor Market Segment by Type
1.2.1 C-21
1.2.2 EMA-401
1.2.3 KDT-501
1.2.4 MOR-107
1.2.5 Others
1.3 Global Angiotensin II Receptor Market Size by Type
1.3.1 Global Angiotensin II Receptor Sales and Growth by Type
1.3.2 Global Angiotensin II Receptor Sales and Market Share by Type (2014-2019)
1.3.3 Global Angiotensin II Receptor Revenue and Market Share by Type (2014-2019)
1.3.4 Global Angiotensin II Receptor Price by Type (2014-2019)
2 Global Angiotensin II Receptor Market Competition by Company
2.1 Global Angiotensin II Receptor Sales and Market Share by Company (2014-2019)
2.2 Global Angiotensin II Receptor Revenue and Share by Company (2014-2019)
2.3 Global Angiotensin II Receptor Price by Company (2014-2019)
2.4 Global Top Players Angiotensin II Receptor Manufacturing Base Distribution, Sales Area, Product Types
2.5 Angiotensin II Receptor Market Competitive Situation and Trends
2.5.1 Angiotensin II Receptor Market Concentration Rate
2.5.2 Global Angiotensin II Receptor Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Angiotensin II Receptor Company Profiles and Sales Data
3.1 CJ HealthCare Corp
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Angiotensin II Receptor Product Category, Application and Specification
3.1.3 CJ HealthCare Corp Angiotensin II Receptor Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 MorphoSys AG
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Angiotensin II Receptor Product Category, Application and Specification
3.2.3 MorphoSys AG Angiotensin II Receptor Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Novartis AG
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Angiotensin II Receptor Product Category, Application and Specification
3.3.3 Novartis AG Angiotensin II Receptor Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Vicore Pharma AB
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Angiotensin II Receptor Product Category, Application and Specification
3.4.3 Vicore Pharma AB Angiotensin II Receptor Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
4 Angiotensin II Receptor Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Angiotensin II Receptor Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Angiotensin II Receptor Sales and Revenue by Regions
4.2.1 Global Angiotensin II Receptor Sales and Market Share by Regions (2014-2019)
4.2.2 Global Angiotensin II Receptor Revenue and Market Share by Regions (2014-2019)
4.2.3 Global Angiotensin II Receptor Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Angiotensin II Receptor Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Angiotensin II Receptor Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Angiotensin II Receptor Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Angiotensin II Receptor Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Angiotensin II Receptor Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Angiotensin II Receptor Application/End Users
5.1 Angiotensin II Receptor Segment by Application
5.1.1 Immunology
5.1.2 Respiratory
5.1.3 Women's Health
5.1.4 Acute Ischemic Stroke
5.1.5 Others
5.2 Global Angiotensin II Receptor Product Segment by Application
5.2.1 Global Angiotensin II Receptor Sales by Application
5.2.2 Global Angiotensin II Receptor Sales and Market Share by Application (2014-2019)
6 Global Angiotensin II Receptor Market Forecast
6.1 Global Angiotensin II Receptor Sales, Revenue Forecast (2019-2025)
6.1.1 Global Angiotensin II Receptor Sales and Growth Rate Forecast (2019-2025)
6.1.1 Global Angiotensin II Receptor Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Angiotensin II Receptor Forecast by Regions
6.2.1 North America Angiotensin II Receptor Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Angiotensin II Receptor Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Angiotensin II Receptor Sales and Revenue Forecast (2019-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Angiotensin II Receptor Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Angiotensin II Receptor Sales and Revenue Forecast (2019-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Angiotensin II Receptor Forecast by Type
6.3.1 Global Angiotensin II Receptor Sales and Revenue Forecast by Type (2019-2025)
6.3.2 C-21 Gowth Forecast
6.3.3 EMA-401 Gowth Forecast
6.4 Angiotensin II Receptor Forecast by Application
6.4.1 Global Angiotensin II Receptor Sales Forecast by Application (2019-2025)
6.4.2 Global Angiotensin II Receptor Forecast in Immunology
6.4.3 Global Angiotensin II Receptor Forecast in Respiratory
7 Angiotensin II Receptor Upstream Raw Materials
7.1 Angiotensin II Receptor Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Angiotensin II Receptor Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
